Insights

Strategic Growth Nu-Med Plus shows recent M&A activity including acquisition of Avid Gold and Canadian gold properties, signaling potential expansion into resource-rich markets and heightened appetite for capital deployment. This suggests cross-selling opportunities for embedded nitric oxide delivery solutions in broader medical and industrial contexts as the company scales.

Healthcare Applications The company focuses on nitric oxide delivery with potential applications in heart disease, respiratory conditions in newborns, wound care, and treatments for malaria, COPD, tuberculosis, and ARDS. Sales opportunities exist across hospital systems, neonatal centers, and specialty clinics seeking innovative therapeutic delivery technologies.

Early Stage & Agile With a small team (2-10 employees) and revenue under one million, Nu-Med Plus is an agile, early-stage partner likely to value flexible pilots, rapid prototyping, and collaborative development. Target opportunities include pilot programs, co-development contracts, and fast-track regulatory support partnerships.

Compliance & Quality Initiatives like pursuing ISO 13485 certification indicate a commitment to quality management for medical devices. This creates a credibility window for suppliers and service providers that align with regulatory requirements, offering opportunities for quality systems consulting, supplier integration, and compliance-focused product enhancements.

Technology & Data The tech stack and emphasis on patented delivery technology suggest opportunities to upsell engineering services, analytics, and integration with hospital IT systems (e.g., data capture for nitric oxide dosing, monitoring, and outcomes tracking) to support deployment and outcome analytics across clinical settings.

Similar companies to Nu-Med Plus

Nu-Med Plus Tech Stack

Nu-Med Plus uses 8 technology products and services including Varnish, WordPress, MySQL, and more. Explore Nu-Med Plus's tech stack below.

  • Varnish
    Caching
  • Content Management System
  • MySQL
    Database
  • Twemoji
    Font Scripts
  • amCharts
    Javascript Graphics
  • Lua
    Programming Languages
  • Google Analytics
    Web Analytics
  • Adobe Fonts
    Web Fonts

Nu-Med Plus's Email Address Formats

Nu-Med Plus uses at least 2 email formats:
Nu-Med Plus Email FormatsExamplePercentage
First@nu-medplus.comJohn@nu-medplus.com
67%
FLast@nu-medplus.comJDoe@nu-medplus.com
33%

Frequently Asked Questions

What is Nu-Med Plus's phone number?

Minus sign iconPlus sign icon
You can contact Nu-Med Plus's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nu-Med Plus's official website and social media links?

Minus sign iconPlus sign icon
Nu-Med Plus's official website is nu-medplus.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Nu-Med Plus generate?

Minus sign iconPlus sign icon
As of November 2026, Nu-Med Plus's annual revenue is estimated to be <$1M.

What is Nu-Med Plus's SIC code and NAICS code?

Minus sign iconPlus sign icon
Nu-Med Plus's SIC code is 3841 - Surgical and Medical Instruments and Apparatus and NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Nu-Med Plus have currently?

Minus sign iconPlus sign icon
As of November 2026, Nu-Med Plus has approximately 2 employees across 2 continents, including North America and Asia. Key team members include Owner: D. C. Explore Nu-Med Plus's employee directory with LeadIQ.

What industry does Nu-Med Plus belong to?

Minus sign iconPlus sign icon
Nu-Med Plus operates in the Medical Equipment Manufacturing industry.

What technology does Nu-Med Plus use?

Minus sign iconPlus sign icon
Nu-Med Plus's tech stack includes Varnish, WordPress, MySQL, Twemoji, amCharts, Lua, Google Analytics and Adobe Fonts.

What is Nu-Med Plus's email format?

Minus sign iconPlus sign icon
Nu-Med Plus's email format typically follows the pattern of First@nu-medplus.com. Find more Nu-Med Plus email formats with LeadIQ.

How much funding has Nu-Med Plus raised to date?

Minus sign iconPlus sign icon
As of November 2026, Nu-Med Plus has raised $992K in funding. The last funding round occurred on Sep 20, 2017 for $660K.

When was Nu-Med Plus founded?

Minus sign iconPlus sign icon
Nu-Med Plus was founded in 2011.
Nu-Med Plus logo

Nu-Med Plus

Medical Equipment ManufacturingUtah, United States2-10 Employees

Nu-Med Plus is a medical device company that designs and develops systems to deliver nitric oxide in precisely controlled doses. The firm is based in Salt Lake City, Utah, and operates with a small team focused on advancing nitric oxide delivery technology. Its work is anchored in patented and patent-pending approaches intended to enable safe administration of nitric oxide for medical use.
Its target applications span cardiology and neonatal care, where appropriately dosed nitric oxide may support vascular dilation and respiratory function, as well as potential uses in wound care and infectious and respiratory conditions such as malaria, COPD, tuberculosis, and ARDS. In the medical equipment manufacturing sector, the company pursues a line of delivery systems and maintains a focus on quality standards, as evidenced by a program launched in 2018 to obtain ISO 13485 certification.

Section iconCompany Overview

Phone number
SIC Code
3841 - Surgical and Medical Instruments and Apparatus
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2011
Employees
2-10

Section iconFunding & Financials

  • $992K

    Nu-Med Plus has raised a total of $992K of funding over 5 rounds. Their latest funding round was raised on Sep 20, 2017 in the amount of $660K as a Post IPO Equity.

  • <$1M

    Nu-Med Plus's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.